Citius Pharmaceuticals (NASDAQ: CTXR), based in New Jersey, focused on specialty pharmaceuticals in adjunctive cancer care and critical care, today announced that the December 6, 2018 presentation from Myron Holubiak, CEO, is now available for on-demand viewing at VirtualInvestorConferences.com.
December 10, 2018
· 2 min read